Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation. - Wikidata - awgldk - TriplyDB

Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation.

Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation.

http://www.wikidata.org/entity/Q35608265

about

Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers Inhibition of cell proliferation by an anti-EGFR aptamer Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines.Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies.Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy Current approaches for predicting a lack of response to anti-EGFR therapy in KRAS wild-type patients Systems analysis of EGF receptor signaling dynamics with microwestern arrays.Monoclonal antibodies: versatile platforms for cancer immunotherapy.Targeting the EGFR signaling pathway in cancer therapy.Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report.IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma.Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab.Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.Recent advances in biomarkers and potential targeted therapies in head and neck squamous cell carcinoma.A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells Signaling multiplex of the epidermal growth factor receptor.Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.Consumption of EGF by A431 cells: evidence for receptor recycling Oleanolic acid induces migration in Mv1Lu and MDA-MB-231 epithelial cells involving EGF receptor and MAP kinases activation.Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity.Role of ErbB Receptors in Cancer Cell Migration and Invasion Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments.Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-Based Cell Targeting.Recent developments in colorectal cancer treatment by monoclonal antibodies.Improved biochemical strategies for targeted delivery of taxoids Anti-EGF receptor monoclonal antibodies: biological studies and potential clinical applications A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis.Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.Antibody Therapeutics in Oncology.Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.Emerging drugs for targeted therapy of bladder cancer.Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000).Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer

P2860

Q24314620-B1A7B7A5-94C0-4F73-BAA3-A9A976FD74DF Q24652337-B710BF52-19D7-4D93-8FE4-1D9BAD1B3526 Q26751473-AEADE0DD-53B9-48D6-B222-027FBAF469F3 Q28743866-24BCB94E-6591-4C21-8C0C-B4655E295265 Q33358967-6891FA1D-F727-4808-95C6-81B07C7E4E4B Q33576327-B6275F49-5503-40DE-ACAB-3C4ADD3F46CF Q33802940-4BE67359-1BB3-46A7-97FF-893A0CB28077 Q33861210-8E60CA7B-4132-48A0-967D-BB9C5F1150DD Q33896605-45BA4CAA-4F31-4266-933E-ED64BC46D986 Q34111693-1B2F3E46-801C-4566-8B25-D3A30CFCBFC2 Q34246558-15453A21-0E4C-4AEE-A200-F529136D9197 Q34263559-4C71AAD4-276D-4FAE-BCF4-F6D260F0D36F Q34294881-3BFB6681-4920-48BD-A74D-E0F5EFF9D6ED Q34451934-1B901160-0046-480E-96E0-EE930FE17BB9 Q34618994-3A2A38F1-EFFD-4B0C-9706-16519E180BA4 Q35001415-619CCD90-166F-4DFA-8AE1-556B65A7C5C4 Q35654360-9261C1CB-744A-4664-B2EC-C7CD54F44C2F Q35825299-1873CF1C-BC94-4C7C-83CD-55D1F84CF19B Q35952148-55A1377E-1EFE-44B8-B4C6-3E5AFC6A5404 Q35973340-F4B6E561-AF63-4689-856B-8537B82381A9 Q35987785-D494761E-9ED0-4A38-974F-79DD427ABD6D Q36108119-F984E3B5-BEA8-43B0-A843-FF18FBE49A3E Q36232210-B8083ACD-08ED-448D-AD74-496C1B692F4D Q36288371-8BDAD79E-8F24-44CF-B9F1-8E7BB0CB899E Q36293949-2C8F7E5A-841F-46F6-BE2D-92F024404381 Q36296101-6CB468A0-D00F-46D5-B598-E20E8FD0E935 Q36311027-79A44DD7-B533-4E1D-9CB4-DC7542B3C8FD Q36557471-D4EA2237-CF16-4855-BCF4-BBF290D9355A Q36592213-32E1BF16-0E94-448E-A8DF-060863CC56F8 Q36627254-0D90CC88-C3A3-4A14-8007-1297A37D8A83 Q36642502-A7644C82-6766-4487-9D04-5FE699350042 Q36646936-D1062F4C-8611-471F-837D-EFF5020BC2E3 Q36757173-A8723737-102D-4F31-A91F-153004B4E9BB Q36788485-078EF1BE-D8F1-494E-B479-D52874AC1981 Q36791878-640D1817-388A-4925-96D2-A574DE6EF6C5 Q36797398-BF02CC2F-D245-4DCF-B2EB-60167B0C48BA Q36918144-DD142B11-156E-4ADB-870C-0BDEC6286A4C Q36944022-69996C70-55EF-461F-9E92-E2A588684433 Q37052752-D4BBF371-958E-49A6-9AC2-F3D8FEA59A53 Q37089778-F54C4587-CAF7-4362-B16C-0F8984B6AD30

P2860

Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation.

http://www.wikidata.org/entity/Q35608265

description

1986 nî lūn-bûn

@nan

1986年の論文

@ja

1986年論文

@yue

1986年論文

@zh-hant

1986年論文

@zh-hk

1986年論文

@zh-mo

1986年論文

@zh-tw

1986年论文

@wuu

1986年论文

@zh

1986年论文

@zh-cn

name

Monoclonal antibody against ep ...... ting receptor phosphorylation.

@ast

Monoclonal antibody against ep ...... ting receptor phosphorylation.

@en

type

label

Monoclonal antibody against ep ...... ting receptor phosphorylation.

@ast

Monoclonal antibody against ep ...... ting receptor phosphorylation.

@en

prefLabel

Monoclonal antibody against ep ...... ting receptor phosphorylation.

@ast

Monoclonal antibody against ep ...... ting receptor phosphorylation.

@en

P1433

Q35608265-718CD895-53AF-4879-9C4C-5A6337F40972

P1476

Q35608265-C4C43713-43D1-41F6-BDCC-ABF0A29BA4D2

P2093

Q35608265-2251D21E-2995-4517-BDAA-309EAABB127B

Q35608265-287EC997-1375-4AD3-8D15-48433153EFB0

Q35608265-4BF79FD0-D8ED-4CAF-BE89-4B3F52471261

Q35608265-D4427AEE-4203-44B9-9C49-17607753B68D

P2860

Q35608265-0DD42B04-E408-4543-9B2F-326E13C7149C

Q35608265-15A9A706-0BE4-4983-BBA7-58ACF616699A

Q35608265-1B796CA7-23C9-49FD-9973-9789EF6A0521

Q35608265-21D636AD-9441-4257-B632-E0B6304B5AC4

Q35608265-3557FBEB-6A1B-4D72-9A8E-4810C0DD374F

Q35608265-747F8561-3B69-4CA6-B87A-DEDC4FE74397

Q35608265-89320BA3-DBF9-4012-AB63-578C408326FB

Q35608265-89504024-8C72-47AA-8FC5-3F9042ED4809

Q35608265-89BF2757-7766-4CBE-8FBF-E3C08BAFC024

Q35608265-9B72FFBB-C182-43D2-BBD7-4BE1F7D0DF7E

P304

Q35608265-AA32E9EA-DC0F-46C5-8F54-CCFD9B68A67A

P31

Q35608265-9A77073B-497B-4ECC-85EB-41BDB1B6050F

P356

Q35608265-E28D7BA6-255D-4C6F-B375-191210D9540D

P407

Q35608265-61267EA0-514C-4ABD-B539-79300C79AE28

P433

Q35608265-90F669E4-B236-4240-A8BD-B109AB8FA8AB

P478

Q35608265-41CB1948-3BF3-4CEE-B07B-864A3419FCF3

P577

Q35608265-863C4BDC-32E6-4AE5-99E8-0E8078D451F0

P5875

Q35608265-2D74F3F2-AC70-4471-87C3-9AED1A6CC9AF

P698

Q35608265-08AD7F6F-0448-4C8B-B799-AC24447C728C

P921

Q35608265-B60677B4-E94E-4B5E-A638-BF8BF7DB686E

Q35608265-EC1FBB09-7087-40DF-ACA7-1D62A1E900DF

P932

Q35608265-9A1AB9D6-D8F8-4B6D-8A0B-C0652CAD0A86

P356

PNAS.83.11.3825

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Monoclonal antibody against ep ...... ting receptor phosphorylation.

@en

P2093

B E Magun

http://www.w3.org/2001/XMLSchema#string

C L MacLeod

http://www.w3.org/2001/XMLSchema#string

H Sunada

http://www.w3.org/2001/XMLSchema#string

J Mendelsohn

http://www.w3.org/2001/XMLSchema#string

P2860

Detection and quantification of phosphotyrosine in proteins

Epidermal growth factor.

Autophosphorylation sites on the epidermal growth factor receptor.

Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture.

Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes.

Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells.

Human squamous cell lung cancers express increased epidermal growth factor receptors.

Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431.

Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors.

The phosphomannosyl recognition system for intracellular and intercellular transport of lysosomal enzymes.

P304

3825-3829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.83.11.3825

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

1986-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20732122

http://www.w3.org/2001/XMLSchema#string

P698

2424012

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

323616

http://www.w3.org/2001/XMLSchema#string